Cidara Therapeutics, Inc. Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 29,794.79%-198.44%-597.59%-85.67%-51.69%-107.65%-13,356.16%
EBIT Margin 29,992.89%-199.49%-595.42%-85.24%-51.98%-116.22%-13,811.92%
EBITDA Margin 27,965.88%-196.47%-597.59%-85.67%-52.11%-98.49%-13,319.76%
Operating Margin 29,992.89%-199.49%-595.42%-85.24%-51.98%-116.22%-13,811.92%
Net Margin 32,864.93%-196.47%-620.48%-85.67%-46.24%9.23%36.39%
FCF Margin 26,958.29%-136.59%-452.45%-51.06%-44.36%-98.51%-13,855.84%
Efficiency
Assets Average 79.07M74.04M64.70M67.87M61.41M57.26M140.91M
Equity Average 59.44M48.49M24.27M16.14M3.57M-11.32M77.55M
Invested Capital 62.41M69.07M47.80M17.74M24.16M-14.44M-7.42M163.88M
Asset Utilization Ratio 0.000.280.190.731.050.410.01
Leverage & Solvency
Interest Coverage Ratio -299.93
Debt to Equity 0.170.170.260.660.12
Debt Ratio 0.120.130.140.120.03
Equity Ratio 0.760.750.550.180.29-0.30-0.120.76
Times Interest Earned -299.93
Valuation
Enterprise Value 173.40M62.31M-9.35M66.61M44.93M22.41M21.43M36.03M-6.76M
Market Capitalization 173.40M137.62M65.22M126.87M87.88M84.69M54.16M71.80M189.41M
Return Ratios
Return on Sales 297.95%-1.98%-5.98%-0.86%-0.52%0.09%0.36%
Return on Capital Employed -1.07%-0.95%-2.75%-1.25%-1.67%2.66%-1.93%
Return on Assets -0.80%-0.56%-1.11%-0.63%-0.55%0.04%0.00%
Return on Equity -1.06%-0.86%-2.97%-2.63%-9.41%-0.19%0.01%